Search
Browse
Statistics
Feeds

Patterns and trajectories of behavioral and neuropsychiatric symptoms in frontotemporal dementia and primary progressive aphasia

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
707kB
[thumbnail of Supplementary Material] Other (Supplementary Material)
324kB

Item Type:Article
Title:Patterns and trajectories of behavioral and neuropsychiatric symptoms in frontotemporal dementia and primary progressive aphasia
Creators Name:Marth, Lena, Martinez-Murcia, Francisco J., Górriz-Sáez, Juan-Manuel, Denecke, Jannis, Ewers, Michael, Prix, Catharina, Stockbauer, Anna Christina, Bernhardt, Alexander Maximilian, Wagemann, Olivia, Wlasich, Elisabeth, Kustermann, Julia, Peters, Oliver, Hellmann-Regen, Julian, Droste Zu Senden, Louise, Priller, Josef, Jakob Spruth, Eike, Spottke, Annika, Asperger, Hannah, Schroeck, Friederike, Gamez, Anna, Schneider, Anja, Fliessbach, Klaus, Dinter, Elisabeth, Linn, Jennifer, Günther, Rene, Wiltfang, Jens, Schott, Björn H., Bähr, Mathias, Zerr, Inga, Flöel, Agnes, Malinowski, Robert, Buerger, Katharina, Janowitz, Daniel, Duzel, Emrah, Glanz, Wenzel, Lüsebrink, Falk, Teipel, Stefan J., Kilimann, Ingo, Prudlo, Johannes, Hermann, Andreas, Synofzik, Matthis, Mengel, David, Beichert, Lukas, Müller, Doreen, Petzold, Gabor C., Yakupov, Renat, Hetzer, Stefan, Dechent, Peter, Scheffler, Klaus, Schönecker, Sonja and Levin, Johannes
Abstract:BACKGROUND AND OBJECTIVES: Behavioral and neuropsychiatric symptoms are common in frontotemporal dementia (FTD) and primary progressive aphasia (PPA). However, little is known about their patterns, time course, and association with brain atrophy. We, therefore, aimed to describe behavioral and neuropsychiatric phenotypes in patients with FTD and PPA, leveraging a hypothesis-free/data-driven approach. METHODS: We included participants diagnosed with behavioral variant FTD (bvFTD) or PPA according to Rascovsky and Gorno-Tempini criteria from the German Center for Neurodegenerative Diseases Clinical Registry Study of Neurodegenerative Diseases-FTD prospective multicenter observational cohort study. Symptoms were assessed using the Neuropsychiatric Inventory-Questionnaire. Principal component analysis (PCA) was used to delineate symptom groups. Subsequently, frequency and severity across diagnostic groups were examined. We applied linear mixed-effects models to describe the longitudinal evolution of symptoms. Associations with MRI-assessed atrophy were investigated using linear regression models. RESULTS: A total of 314 patients (42.4% female, mean age 65.52 [SD 9.0] years) with bvFTD or PPA were included. MRI was available for 134 of 314 individuals. PCA revealed 4 natural symptom groups, labeled active behavioral, passive behavioral, affective, and psychotic phenotypes. Symptom groups were observed at comparable frequencies across diagnostic groups. Time from symptom onset (0.130 [0.044–0.217], p < 0.003), sex (1.376 [0.666–2.087], p < 0.001), and the interaction between the nonfluent variant of PPA and sex (−1.940 [−3.242 to −0.638], p = 0.004) showed a significant effect on the active behavioral phenotype, with symptom severity increasing over time and being most pronounced in men with bvFTD. Patients with bvFTD exhibited more severe passive behavioral symptoms compared with any other diagnostic group. For the affective phenotype, a significant interaction between time and sex (0.063 [0.010–0.117], p = 0.021) indicated a progressive increase in symptom severity in men over time. Furthermore, we found robust neuroanatomical correlations of passive behavioral symptoms with subcortical and bilateral frontal and cingulate cortical atrophy. DISCUSSION: Our findings demonstrate that behavioral and neuropsychiatric symptoms are prevalent in both bvFTD and PPA. Their severity depends on the disease duration, phenotypic group, and sex. This detailed understanding of symptomatology is crucial for optimizing patient care, diagnostic evaluations, and the design of clinical trials. Limitations comprise the lack of neuropathologic validation and the limited availability of MRI data.
Keywords:Atrophy, Brain, Cohort Studies, Disease Progression, Frontotemporal Dementia, Magnetic Resonance Imaging, Neuropsychological Tests, Primary Progressive Aphasia, Prospective Studies
Source:Neurology
ISSN:0028-3878
Publisher:American Academy of Neurology
Volume:106
Number:4
Page Range:e214510
Date:24 February 2026
Official Publication:https://doi.org/10.1212/wnl.0000000000214510
PubMed:View item in PubMed
Related to:

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library